Workshop, sponsored jointly by the Immunotoxicology and Inhalation Speciality Sections of the SOT, sought to consider and discuss the current methods that are available and opportunities that may exist for the prospective identification of chemicals and proteins that have the potential to induce sensitization of the respiratory tract and cause occupational asthma. It is recognized that xenobiotics may provoke respiratory toxicity of several types by a variety of mechanisms. The focus of this Workshop was, however, on examination of those chemicals and proteins that cause respiratory effects secondary to the stimulation of a specific immune response. This is consistent with a working definition of allergy being the adverse health effects resulting from the induction of specific immune responses. The Workshop was designed to build upon and extend recent considerations of the toxicological and occupational health issues that respiratory allergy poses (Briatico-Vangosa et ai, 1994; Selgrade et al., 1994) .
One particular problem posed by occupational respiratory allergy is that, unlike the situation with respect to contact sensitization, there are no widely recognized or well-validated predictive tests. In the course of the Workshop, methods available in guinea pigs and mice and the use of structure-activity relationships were described in the context of a clinical perspective and regulatory requirements. relevant in some instances (Bernstein and Bernstein, 1994) . Little is known of the risk factors for the development of respiratory allergy. It is clear, however, that in the occupational setting, as the extent and duration of exposure to the inducing allergen increases, so does the likelihood of sensitization and clinical disease. Atopy has been demonstrated to be an important risk factor for the development of occupational rhinitis and asthma to protein aeroallergens, but a similar correlation has been found only infrequently for chemical sensitizers. Smoking is a variable risk factor for occupational asthma. It has been proposed recently that certain HLA alleles may show associations with chronic immune-mediated berylliosis and with diisocyanate-induced asthma.
There is clear evidence that allergic respiratory hypersensitivity to proteins is mediated by IgE antibody-dependent mechanisms. The situation with respect to chemical respiratory allergens is less certain and more controversial. Although specific IgE antibody for many chemical respiratory sensitizers has been demonstrated, it is true that in many instances individuals who clearly display the symptoms of chemical-induced respiratory allergy lack detectable IgE. It may be that in some cases it is specific IgG4 antibody, rather than IgE, that effects sensitization. Alternatively, or additionally, cell-mediated immune responses may play an important role. There is evidence that respiratory allergy may be associated with the selective activation of T helper (Th) type 2 lymphocytes. Certainly the presence of these cells and their cytokine products will facilitate the accumulation of eosinophils that characterizes the chronic bronchial inflammation associated with asthma. In contrast, sensitivity to beryllium, as manifested by chronic interstitial pneumonitis in workers exposed for long periods of time to the metal is induced by classical delayed-type hypersensitivity mechanisms mediated by Thl-type cells (Newman. 1994) .
Objective assessment of lung function is essential for the evaluation of occupational respiratory allergic diseases. The most convenient strategy is assessment of serial peak expiratory flow rates for periods of 2 to 3 weeks at and away from work. If these comparative tests are suspicious, then measurements of nonspecific airway hyperresponsiveness may be used to record changes that have occurred resulting from the workplace environment. If this series of tests proves not to be diagnostic, then a specific inhalation challenge under controlled laboratory conditions may be required for confirmation and for identification of the causative allergen (Fig. 1) . Chest X-rays are usually normal in cases of occupational asthma, but they may be helpful in the diagnosis of pulmonary fibrosis or hypersensitivity pneumonitis. Lung diffusing capacity is usually decreased in hypersensitivity pneumonitis and pulmonary fibrosis, but is normal in occupational asthma.
The most important principle of treatment is early removal of the individual from further exposure. At times, barrier equipment may be required for agents that cannot be ventilated adequately by routine measures.
Structure-Activity Relationships in Respiratory
Sensitization (Meryl H. Karol) Previous computational methods for the analysis of the relationships between structure and activity of respiratory allergens have focused only upon electrophilic potential (Agius et ai, 1991) . A structure-activity evaluation of chemicals associated with respiratory sensitization has been conducted recently using a computer-based expert system, CASE/MultiCASE (Klopman, 1992) . This system does not rely upon a preconceived mechanism of activity. Using a database comprising 39 chemicals known to cause respiratory hypersensitivity in humans, the system was able to identify structural alerts (fragments) associated with activity. CASE/MultiCASE operates by fragmenting chemicals into substructures containing two or more heavy (nonhydrogen) atoms. The fragments found in active compounds are then compared with those found in inactive chemicals and in this way fragments that are associated statistically with activity are identified.
The chemicals that comprised the database were selected with care from the medical literature with emphasis being placed on elicitation of a hypersensitivity response. Inclusion criteria included the purity of the chemical, that inhalation had been performed with a nonirritating concentration, and that such challenge had resulted in a respiratory reaction characterized by a drop in pulmonary function (FEV,) of 20% or greater. Among the active chemicals selected were diisocyanates, acid anhydrides, and dyes. However, no "inactive" chemicals (those yielding negative responses when tested) were identified from the literature. Accordingly, the assumption was made that chemicals inactive in causing contact sensitization would fail also to cause respiratory sensitization. Included as negatives in the database therefore were chemicals known not to cause skin sensitization (Graham et ai, 1996) .
The structural alerts (biophores) identified that were associated statistically with respiratory allergens included the isocyanate functionality, amines, aromatic fragments, acid functionalities, and distance descriptors. In addition, active chemicals were found to have a greater mean molecular mass, lower log p, and increased water solubility compared with inactive chemicals. Moreover, highest occupied molecular orbital (HOMO) and lowest nonoccupied molecular orbital (LUMO) energies differed between the two groups. The basis for the prediction of toluene diisocyanate (TDI) being a respiratory allergen is shown in Fig. 2 . In this case the evaluation indicated the presence of three biophores and the probability of respiratory-sensitizing activity was considered to be 99.2%.
Validation studies have commenced using known respiratory allergens, removing chemicals from the dataset, creating new models, and testing the activity of the excluded chemicals. Experience to date indicates a sensitivity of 82% and a specificity of 91%.
Analyses have revealed that some physicochemical properties of respiratory allergens differ markedly from contact allergens and that only with the former are some biophores (such as O=C=N-and HO-C=C) identified. Such data may provide the basis for exploring biomechanisms.
Guinea Pig Methods (Kathy Sarlo)
Guinea pigs have represented the species of choice for models of respiratory hypersensitivity reactions and have been used to investigate both protein and chemical allergens.
Methods for assessment of protein allergenicity were developed for investigation of detergent enzymes. The model allergen has been subtilisin, for which a threshold limit value has been established (ACGIH, 1990). Extensive human data for this enzyme exist (Flood et al., 1985; Sarlo et al., 1990) and provide a basis for comparisons between humans and guinea pig. An inhalation induction model for sensitizing guinea pigs to protein aerosols was developed by Karol et al. (1985) and used successfully for sensitization of animals to subtilisin (Thorne et al., 1986; Hillebrand et al., 1987) . Animals exposed to 150 Hg subtilisin/m 3 for 15 min per day for five consecutive days developed immediate-and late-onset pulmonary responses following challenge. In addition, some animals displayed allergic antibody (IgGl in the guinea pig).
Another approach is the guinea pig intratracheal test (GPIT) in which animals are dosed intratracheally with the test protein weekly for 10 to 12 consecutive weeks (Ritz et al., 1993) . Guinea pigs are observed for signs of pulmonary reactions following each exposure. Using subtilisin, results comparable with the inhalation method have been obtained using this approach and the GPIT has been used to measure the relative sensitizing potential of new detergent enzymes for the development of operational exposure guidelines . Finally, with respect to protein allergenicity, an injection method has been described in which guinea pigs are exposed intradermally to the test material and activity is assessed as a function of antibody production, rather than the elicitation of pulmonary responses (Blaikie et al., 1994) .
Guinea pig methods for the measurement of chemicalinduced respiratory allergy rely upon the evaluation of challenge-induced pulmonary reactions in previously sensitized animals, combined with the assessment of allergic antibody production. Challenge is performed using an atmosphere of either the free chemical or a chemical-protein conjugate, the latter being mandatory in some cases . Conventionally, guinea pigs are sensitized either by inhalation or by injection.
The guinea pig inhalation model for chemical respiratory sensitizers was developed first by Karol (1983) and used to examine responses to TDI. Animals were housed in whole body plethysmographs and responses that were induced in inhalation-sensitized guinea pigs following challenge with an aerosol of the inducing chemical linked to a protein carrier were measured. Similar methods have been employed successfully to measure responses to other chemical respiratory allergens including diphenylmethane diisocyanate (MDI; Karol and Thome, 1988) , trimellitic anhydride (TMA; 1988, Pauluhn and Eben, 1991) , and phthalic anhydride (PA; Sarlo and Clark, 1992) . In contrast, it proved impossible to elicit pulmonary responses to two other chemical respiratory allergens, reactive black B dye, or a procion yellow dye, using challenge with either the free chemical or a protein conjugate (Sarlo and Clark, 1992; Botham et al, 1988) . However, in these cases allergic antibody was detected.
Guinea pig injection models have been proposed, their advantage being that sensitization can be achieved without the need for inhalation exposure (Botham et al., 1989; Pauluhn and Eben, 1991; Sarlo and Clark, 1992; Rattray et al., 1994; Blaikie et al., 1995) . In a recent collaborative trial pulmonary responses were elicited by inhalation challenge with the free chemical in guinea pigs sensitized to TMA, MDI, or PA. Guinea pigs sensitized by injection with TDI responded only to an atmosphere of TDI conjugate. In all cases allergic antibody was detected. In contrast, 2,4-dinitrochlorobenzene (DNCB), a contact allergen that lacks the potential to cause sensitization of the respiratory tract, induced neither pulmonary responses nor allergic antibody (Blaikie et al., 1995) .
Analysis of allergic antibody responses following injection of chemical has also been proposed as an important step in a tiered approach to the evaluation of respiratorysensitizing activity (Sarlo and Clark, 1992) .
Guinea pigs have provided useful models for investigation of respiratory sensitization to protein and chemical allergens. However, the cost of such investigations can be prohibitive in the context of routine screening and for this reason there has recently been some interest in the development of predictive test methods in mice.
Approaches to the Identification of Chemical Respiratory Sensitizers in Mice (Ian Kimber)
Two approaches to the identification of respiratory chemical allergens in mice have been described. Both have as their theoretical foundation the fact that chemical allergens of different types induce in mice divergent immune responses characteristic of the selective activation of discrete T lymphocyte subpopulations. Contact allergens, such as DNCB, that are considered not to cause sensitization of the respiratory tract provoke in BALB/c mice Thl-type immune responses that are associated with the elaboration of high levels of interferon-'y (IFN-y; a Thl cell product) and the appearance of IgG2a anti-hapten antibody. Exposure of mice to DNCB does not, however, provoke an IgE antibody response. Conversely, exposure of mice, under the same conditions, to chemical respiratory allergens results instead in the generation of selective Th2-type immune responses. In this case there is the preferential production of Th2 cell cytokines, such as interleukins 4 and 10 (IL-4 and IL-10) and the induction of an IgE antibody response Kimber, 1991, 1992; Dearman et al, , 1994 Dearman et al, , 1995 . Differences exist also with respect to the ability of chemical allergens to provoke in mice an increase in the serum concentration of IgE. It was found that chemical allergens known to cause respiratory sensitization and occupational asthma (including TMA, TDI, PA, and MDI) when applied topically to BALB/c strain mice induced a substantial increase in serum IgE concentration relative to levels found in naive animals, or in concurrent vehicle-treated controls. In contrast, those chemicals known or suspected not to cause sensitization of the respiratory tract in humans, but which nevertheless display contact sensitizing activity, fail to stimulate similar changes. Among these latter chemicals DNCB, oxazolone, and isoeugenol are included (Kimber and Dearman, 1993; Kimber, 1996) . These observations form the basis of the mouse IgE test, a novel approach to the prospective identification of chemicals that have a potential to cause respiratory sensitization Hilton et al, 1995) . In practice, assays are performed using three concentrations of the test material together with TMA and DNCB which serve, respectively, as positive and negative controls. Recent investigations of TMA and DNCB have shown them consistently to display differential activity in the test, with only the former provoking a significant increase in the serum concentration of IgE (Hilton et al, 1996) .
There is as yet little confirmatory evidence from independent laboratories regarding the utility of the method, although Potter and Wederbrand (1995) have reported similar, but not identical, results using BALB/c mice. Preliminary data suggest also that a variant of the method developed in Brown Norway rats is able to distinguish in a similar way between TMA and DNCB with respect to induced increases in serum IgE concentration (Arts et al, 1995) .
While the mouse IgE test potentially offers advantages of cost and speed, it is not without limitations. Not least of these is the fact that the method seeks to identify chemicals that have the potential to induce the quality of immune response required for sensitization of the respiratory tract. It is not necessarily the case that hazard identified in this way will translate into a risk of respiratory allergy in humans. Irrespective of perceived benefits and drawbacks, the method must be considered as being as yet unvalidated. More experience must be gained and evaluations performed with a wider range of chemicals before recommendations can be made regarding the possible contribution of this test to the routine toxicological assessment of sensitizing activity.
A second approach developed in mice is cytokine fingerprinting. As described above, the qualitatively divergent immune responses induced in mice by chemicals such as TMA and DNCB are associated with selective cytokine secretion profiles by draining lymph node cells. Experience to date indicates that the phenotype of preferential cytokine production takes time to develop during the maturation of immune responses to chemical allergens. Early following treatment lymph node cells draining the site of topical exposure to both chemical respiratory and contact allergens produce comparable cytokine profiles. However, following more chronic exposure a pattern of selective cytokine production develops such that contact allergens are associated primarily with type 1 cytokines and respiratory allergens with type 2 cytokines. Thus, repeated topical exposure of mice to TMA over a 13-day period results in the production by draining lymph node cells of high levels of IL-10 and mitogen-inducible IL-4, but only comparatively low levels of IFN-y. With DNCB the converse pattern is observed (Dearman et ai, 1995) . Recent experiments indicate that TDI and 2,4-dinitrofluorobenzene (DNFB; a potent contact allergen) induce in mice a similar divergence of cytokine secretion, with the former selectively stimulating IL-4 and IL-10 production and the latter IFN-y production (Dearman et ai, 1996) .
It is proposed that it may therefore be possible to classify chemical allergens as a function of induced cytokine secretion profiles. It is suggested that cytokine production patterns stimulated by the test chemical be compared with those provoked concurrently by TMA and DNCB serving, respectively, as controls for respiratory and contact sensitizing activity. An example of such an approach, in which the production by draining lymph node cells of IL-4, IL-10, and IFNy following chronic exposure of mice to MDI is compared with cytokine secretion induced by TMA and DNCB, is illustrated in Fig. 3 .
The development of cytokine fingerprinting as an integrated method for the simultaneous identification and classification of chemical allergens is still in its infancy. Although early indications are promising, further evaluation is required.
Mouse Methods to Assess the Relative Allergenicity of Proteins (Michael K. Robinson)
The mouse has been used for many years in the investigation of allergic responses to proteins (Inagaki et al, 1985; Henderson et al., 1985 Henderson et al., , 1987 Takafuji et al., 1987) . On the basis of IgE production, mice can be divided into high, medium, and low responder strains (Revoltella and Ovary, 1969; Mancino and Ovary, 1980) . Different immunization regimes, with a variety of protein allergens, have been used and parameters measured have included cellular immune responses, the production of IgE antibody and antibody of other isotypes, antigen presentation, cellular proliferation, and allergic inflammation. More recently the mouse has begun to find favor as a model for respiratory hypersensitivity and airway hyperresponsiveness (Renz et ai, 1992; Lack et al., 1994) .
There is interest in the use of the mouse to develop methods to assess the relative potency of enzymes as respiratory allergens for the determination of threshold limit values and operational exposure guidelines. As described above, the approach usually is to compare responses to test proteins with those induced by the protease subtilisin. Recently, measurement of the relative sensitization potential of proteins, including subtilisin, following intraperitoneal exposure of mice has been described (Hilton et al., 1994) . However, most attention has focused upon responses induced when proteins are delivered by routes more relevant to those of occupational exposure. In this context two model systems, an intratracheal exposure method and an intranasal dosing method, have been developed. In both approaches specific antibody responses are measured as a function of the dose of antigen administered, the dosing matrix, and the isotypes of antibodies produced.
In the intratracheal method (Kawabata et al., 1996) mice are dosed with varying amounts of enzyme in saline, or with saline containing a detergent mix, directly into the trachea. After multiple weekly exposures, sera are drawn and analyzed for specific IgGl antibody (using an enzyme-linked immunosorbent assay) and for specific IgE antibody (using [ 3 H]serotonin release from the basophil cell line RBL 2H3). Using subtilisin as the benchmark allergen, peak antibody responses were observed after 6-8 weeks of dosing with titers of between 1:1024 and 1:8192 being typical for IgGl and of 1:32 to 1:256 for IgE. In both cases antibody responses were augmented in the presence of detergent (Kawabata et ai, 1996) . Although differences in potency between proteins were apparent, dose-response profiles were found generally to be flat, thus prohibiting precise estimation of the degree of such differences (Fig. 4) . For this reason, and because the intratracheal method was demanding technically, attempts were made to pursue an approach based upon intranasal administration.
Like the intratracheal model, the intranasal method involves repeated administration to mice of low volumes of enzyme in either saline or a detergent mix. Mice are given 5 [A of enzyme solution into each nostril on each of 3 days (Days 1, 3, and 10 Groups of mice (n = 10) received 50 /xl of l% DNCB, 2% MDI, or 10% TMA (all in 4:1 acetone:olive oil; AOO) bilaterally on both shaved flanks. Five days later this treatment was repeated. After a further 5 days. 25 fi\ of chemical was applied to the dorsum of both ears daily for 3 consecutive days. One day following the final exposure mice were killed and draining auricular lymph nodes were excised and pooled for each experimental group. A single cell suspension of lymph node cells was prepared and cultured in the presence (for measurement of mitogen-inducible IL-4 production) or absence (for the measurement of spontaneous IL-10 and IFN-y secretion) of 2 ^g/ml concanavalin A. Culture was terminated after various periods and the concentration of IL-4, IL-10, and IFN-y was measured in supematants by enzyme-linked immunosorbent assay. In each instance cytokine concentrations are recorded as mean values in ng/ml. Standard errors were less than 10% of mean. . ; study, the mice were administered enzymes weekly for 4 weeks. For the intranasal (i.n.) study, the mice were administered enzymes on Days I, 3, and 10. Blood samples were collected 5 days after the final enzyme dose in both studies. Antienzyme IgGl was assayed by an antigen capture ELISA and IgE assayed by an RBL 2H3 cell serotonin release assay as described elsewhere (Kawabata et ai, 1996) . Logistic curves were fitted to the i.n. IgGl data using SigmaPlot curve-fitting software.
body responses to subtilisin were obtained with titers ranging from 0 to 1:8192. This in turn enabled derivation of ED50 values and on this basis it was found that the IgGl response to subtilisin was enhanced fourfold in the presence of detergent when compared with antigen in saline controls. Using the exposure regime described above, it has not been possible to induce a consistent IgE response. Although low-level IgE antibody has been stimulated by longer exposure protocols, the use of these may negate the advantages of simplicity and cost that this method offers. Presently, therefore, IgGl antibody is used as a surrogate endpoint for assessment of the differential allergic potency of enzyme proteins. IgGl is not, however, irrelevant in terms of sensitization. It is coregulated in the mouse by the IL-4/Th2 pathway, in similar fashion to IgG4 mentioned above as being possibly involved in clinical respiratory allergy. Also, it is known that anaphylactic responses to protein can occur in mice in association with robust IgGl, but undetectable IgE responses (Oettgen et ai, 1994; Lei et ai, 1996) . As illustrated in Fig. 4 , the measurement of IgGl antibody responses following intranasal administration has provided a method for assessment of relative potency. In this example subtilisin has been compared with amylase and found to be 4.8 times less potent; a figure that compares favorably with results obtained using the GPIT (Sarlo et ai, 1991) .
Effort continues toward the further refinement of the method with respect to measurement of specific IgE responses. Notwithstanding this, it is believed that intranasal administration linked with the measurement of IgGl antibody production provides a useful method for assessing the relative potential of proteins to induce respiratory sensitization.
Potential Applications to Regulatory Needs and Risk
Assessment (MaryJane K. Selgrade) In the regulatory arena there are several situations where data on the potential allergenicity of materials are required. The needs depend upon the objectives of a particular activity. Two examples of situations where the Environmental Protection Agency (EPA) has occasion to use data on respiratory allergenicity are provided here to illustrate the point: premanufacturing notices (PMNs) required for the review of new chemicals under the Toxic Substances Control Act (TSCA) and the setting of inhalation reference concentrations (RfC).
Regulation usually requires some form of risk assessment. As defined by the National Research Council (NRC, 1983) , risk assessment includes some or all of the following four components: hazard identification, dose-response data, exposure assessment, and risk characterization. Hazard identification addresses the question, in the context of this Workshop report, whether a chemical or protein has the inherent ability to cause sensitization of the respiratory tract. Doseresponse relationships are relevant to considerations of relative potency and under what conditions of exposure adverse effects are likely to develop. Dose-response assessments for potential respiratory allergens are complicated by the fact that there are two exposure conditions to consider, those that will result in sensitization of a naive individual and those that will elicit an allergic reaction in a sensitized individual. Exposure assessment considers the nature and extent of human exposure that is likely to occur. Relevant information includes the intended use of a chemical or protein, production volume, containment measures, and monitoring data. Finally, all of the above information is synthesized to provide a characterization of risk.
Under the New Chemicals Program, Section 5 of TSCA, a determination of "unreasonable risk to human health and/ or the environment" must be made within a 90-day period for each of approximately 2000 chemicals submitted each year. A PMN is required that must include information on chemical structure, manufacturing methods, intended use of the chemical as either an intermediate or final product, estimated annual production volume, potential environmental and/or occupational exposures, and any available toxicity data. For about 50% of chemicals submitted there are no available toxicity data and for others data are sparse. By necessity, therefore, evaluation of chemicals in the PMN process relies primarily upon exposure assessment and structure-activity relationships. Two chemical classes, isocya-nates and anhydrides, are considered to be potential respiratory sensitizers and if certain criteria are met (M T <3000; equivalent weight <1000), then the EPA can request that additional tests be conducted. If production is estimated to be approximately 100,000 pounds per year, then a few inexpensive tests may be requested. If, however, production is calculated to exceed 1 million pounds, then more expensive analyses may be asked for. Clearly what is required for chemical respiratory allergens is a quick and relatively inexpensive screening method. Some years ago the EPA held a workshop (Selgrade et al, 1994) at which it was concluded that the mouse IgE test, if properly validated, might meet this need. It is clear also that attempts to improve understanding of the relationship between chemical structure and respiratory-sensitizing activity would be extremely valuable in the PMN process. Concern would, in addition, be raised by a positive indication that a chemical was able to haptenate a carrier protein in vitro. The aim is for the EPA to have sufficient data to negotiate control measures with the manufacturer. There is no doubt that a robust screening method would find application in other arenas and progress to that end is described in this report.
In contrast, far more information than that provided by the results of a screening test is required for the EPA to set an RfC. An RfC is defined as "an estimate (with uncertainty spanning perhaps an order of magnitude) of a continuous inhalation exposure to the human population (including sensitive subgroups) that is likely to be without appreciable risk of deleterious noncancer health effects during a lifetime" (EPA, 1994) . The RfC is a dose-response estimate and requires dose-response data, which for respiratory sensitizers appear presently to be obtainable only from guinea pig inhalation models, or from intratracheal exposure models provided that extrapolation from tracheal to inhalation exposure can be made. The fact that the doses required for sensitization and for elicitation of a hypersensitivity reaction in a sensitized individual will be different complicates the assessment. For example, there is a debate whether sensitized individuals represent a sensitive subpopulation. For these reasons respiratory allergens pose a particular problem in the RfC process. Similar problems are encountered in deriving threshold limit values for safe occupational exposure.
Between the two examples discussed there are likely to be other needs for identifying potential respiratory allergens. Further development of the methods described here, or of new approaches based upon a more detailed understanding of relevant mechanisms, may satisfy requirements in some or all of these areas.
General Discussion
The general discussion that followed the presentations at the Workshop highlighted a number of issues of importance with respect to the prospective identification of respiratorysensitizing chemicals and proteins. Key points not addressed above are highlighted briefly below.
(a) It was recognized that the further evaluation and validation of SAR methods and animal predictive tests would require access to chemicals for which there exists solid clinical information regarding their ability, or lack of ability, to cause sensitization of the respiratory tract. Of particular difficulty is the identification of reliable negative controls that can be used to explore the selectivity of new test methods. In this context it may prove helpful that an ECETOC (European Centre for Ecotoxicology and Toxicology of Chemicals) task force has recently proposed chemicals that may be used as positive and negative controls in the assessment of methods proposed for the identification of contact or respiratory-sensitizing chemicals. This information should be available during 1996.
(b) The role of irritation in the induction of pulmonary immune responses to chemical and protein allergens was identified as a possible confounding factor in assessment of sensitizing activity. The view expressed was that local irritation is believed to enhance the induction of contact sensitization following topical exposure to chemical allergens and that there is no reason to suppose that similar mechanisms will not be relevant in the respiratory tract.
(c) The routes of exposure relevant for the induction of respiratory sensitization to chemical allergens were considered. While it is clear that inhalation of chemicals represents the most important route of exposure for occupational sensitization, there is both clinical and experimental evidence to suggest that effective sensitization of the respiratory tract may be achieved also following dermal contact, resulting usually from industrial accidents, splashes, or spillages.
(d) Optimal screening strategies were discussed and there was support for the view that the most desirable first step in any assessment process was consideration of structureactivity relationships.
Conclusions
The Workshop reported here demonstrated that in recent years advances have been made in the development of methods for the identification of chemical and protein respiratory allergens. It is clear, however, that respiratory sensitization poses important toxicological and occupational health questions and that much must still be achieved in developing practical and effective methods for the prospective identification of respiratory allergens.
